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Bilateral Choroidal Metastases from Mesothelioma
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(J Thorac Oncol. 2006;1: 712–713)
Choroidal metastases are uncommon. Most reported casesof choroidal metastases are from breast or lung cancer.1
We have not been able to find any reports of choroidal
metastases developing in a patient with mesothelioma. Here
we present such a case.
CASE REPORT
A 69-year-old retired carpenter with previous asbestos
exposure was diagnosed with pleural epithelioid mesotheli-
oma in 2003. He was treated with a pleural decortication but
subsequently relapsed in supraclavicular and axillary lymph
nodes and in the peritoneum. He was treated with palliative
radiotherapy to symptomatic sites and then with chemother-
apy, including pemetrexed, carboplatin, and gemcitabine.
After initial response, his disease progressed.
In late 2005, he presented with rapidly progressive loss
of vision. Ophthalmologic assessment revealed bilateral cho-
roidal lesions consistent with metastatic deposits (Figures 1
and 2). Differential diagnoses included choroidal melanomas,
especially amelanotic melanomas, and benign lesions such as
hemangiomas, and inflammatory granulomas.1 The presence
of multiple lesions in one eye and the involvement of both
eyes in the setting of known metastatic mesothelioma estab-
lished the diagnosis of choroidal metastases.1
Computed tomography scans of the brain, orbit, chest,
abdomen, and pelvis were also performed showing overall
progression of disease within the mediastinum, abdomen,
peritoneum, and lungs and possible cerebellar metastasis
(Figure 3).
He was treated with dexamethasone and bilateral
orbital irradiation to a dose of 30 Gy in 10 fractions using
6-MV photons. Following completion of radiotherapy,
his vision stabilized, and 2 months after treatment, he is
able to read, although with some difficulty. The patient is
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FIGURE 1. Fundoscopic view of left orbit.
FIGURE 2. Fundoscopic view of right orbit.
FIGURE 3. Computed tomography scan of brain and orbit
showing left choroidal lesion.
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alive 5 months after his presentation with choroidal me-
tastases, and 3 years after his initial diagnosis. Unfortu-
nately, his systemic metastatic disease continues to
progress, requiring further palliative radiotherapy for
symptom control.
Although mesothelioma is not usually considered a
radiosensitive disease, useful palliation of symptoms arising
from localized deposits can often be achieved with modest
doses of radiotherapy as we have demonstrated here and
previously.2
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